Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Depreciation & Amortization (CF) (2016 - 2020)

Historic Depreciation & Amortization (CF) for Larimar Therapeutics (LRMR) over the last 8 years, with Q4 2020 value amounting to $50000.0.

  • Larimar Therapeutics' Depreciation & Amortization (CF) rose 15000.0% to $50000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $155000.0, marking a year-over-year increase of 9871.79%. This contributed to the annual value of $318000.0 for FY2024, which is 225.08% up from last year.
  • According to the latest figures from Q4 2020, Larimar Therapeutics' Depreciation & Amortization (CF) is $50000.0, which was up 15000.0% from $50000.0 recorded in Q3 2020.
  • Larimar Therapeutics' 5-year Depreciation & Amortization (CF) high stood at $107000.0 for Q3 2018, and its period low was -$13000.0 during Q2 2019.
  • In the last 5 years, Larimar Therapeutics' Depreciation & Amortization (CF) had a median value of $50000.0 in 2016 and averaged $44700.0.
  • In the last 5 years, Larimar Therapeutics' Depreciation & Amortization (CF) soared by 90000.0% in 2016 and then plummeted by 12500.0% in 2019.
  • Quarter analysis of 5 years shows Larimar Therapeutics' Depreciation & Amortization (CF) stood at $61000.0 in 2016, then decreased by 18.03% to $50000.0 in 2017, then increased by 4.0% to $52000.0 in 2018, then plummeted by 61.54% to $20000.0 in 2019, then skyrocketed by 150.0% to $50000.0 in 2020.
  • Its Depreciation & Amortization (CF) stands at $50000.0 for Q4 2020, versus $50000.0 for Q3 2020 and $32000.0 for Q2 2020.